VISHEE(SH:688580) Sou Hu Cai Jing·2026-01-06 18:44Core Viewpoint - Weisi Medical (688580) has experienced significant stock price movement, with a closing price of 69.7 yuan on January 6, 2026, marking a 20.01% increase and achieving a consecutive two-day limit-up [1]. Group 1: Trading Information - On January 6, 2026, the net inflow of main funds was 8.11 million yuan, indicating increased attention from institutional investors [3][6]. - The stock was listed on the "Dragon and Tiger List" due to its price increase deviation reaching 15% and a cumulative increase of 30% over three trading days [4][6]. Group 2: Company Announcements - Weisi Medical announced that its stock price had deviated significantly, with a cumulative increase exceeding 30% over three consecutive trading days, but confirmed that there were no undisclosed major issues and that operations remain normal [5]. - The company focuses on rehabilitation medical devices, with its brain-computer interface products still in the early stages of market cultivation and contributing limited revenue [5][6]. - For the first three quarters of 2025, Weisi Medical reported a revenue of 326 million yuan, representing a year-on-year growth of 11.58%, and a net profit attributable to shareholders of 102 million yuan, reflecting a year-on-year increase of 30.68% [5][6].